 | • レポートコード：GIR201115711 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、体外大腸がんスクリーニング検査の世界市場を調査対象にし、体外大腸がんスクリーニング検査の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（バイオマーカー検査、便潜血検査、CRCDNAスクリーニング検査）、用途別分析（病院及び診療所、外来、在宅ケア）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Alere(Abbott)、QIAGEN、Eiken Chemical、Beckman Coulter、Sysmex、Siemens Healthcare、Immunostics、Clinical Genomics Pty Ltd (Quest Diagnostics)、Hitachi Chemical (Kyowa Medex)、R-Biopharm ・企業別売上、市場シェア ・体外大腸がんスクリーニング検査の地域別市場分析 ・体外大腸がんスクリーニング検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・体外大腸がんスクリーニング検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・体外大腸がんスクリーニング検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・体外大腸がんスクリーニング検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・体外大腸がんスクリーニング検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・体外大腸がんスクリーニング検査の種類別市場規模2015-2020：バイオマーカー検査、便潜血検査、CRCDNAスクリーニング検査 ・体外大腸がんスクリーニング検査の用途別市場規模2015-2020：病院及び診療所、外来、在宅ケア ・体外大腸がんスクリーニング検査の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global In-Vitro Colorectal Cancer Screening Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1185 million by 2025, from USD 964.8 million in 2019.
The In-Vitro Colorectal Cancer Screening Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
In-Vitro Colorectal Cancer Screening Tests market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, In-Vitro Colorectal Cancer Screening Tests market has been segmented into:
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
By Application, In-Vitro Colorectal Cancer Screening Tests has been segmented into:
Hospital and Clinics
Ambulatory
Home Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global In-Vitro Colorectal Cancer Screening Tests market presented in the report. This section sheds light on the sales growth of different regional and country-level In-Vitro Colorectal Cancer Screening Tests markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global In-Vitro Colorectal Cancer Screening Tests market.
The report offers in-depth assessment of the growth and other aspects of the In-Vitro Colorectal Cancer Screening Tests market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and In-Vitro Colorectal Cancer Screening Tests Market Share Analysis
In-Vitro Colorectal Cancer Screening Tests competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, In-Vitro Colorectal Cancer Screening Tests sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the In-Vitro Colorectal Cancer Screening Tests sales, revenue and market share for each player covered in this report.
The major players covered in In-Vitro Colorectal Cancer Screening Tests are:
Alere(Abbott)
QIAGEN
Eiken Chemical
Beckman Coulter
Sysmex
Siemens Healthcare
Immunostics
Clinical Genomics Pty Ltd (Quest Diagnostics)
Hitachi Chemical (Kyowa Medex)
R-Biopharm
1 In-Vitro Colorectal Cancer Screening Tests Market Overview
1.1 Product Overview and Scope of In-Vitro Colorectal Cancer Screening Tests
1.2 Classification of In-Vitro Colorectal Cancer Screening Tests by Type
1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type in 2019
1.2.3 Biomarker Tests
1.2.4 Fecal Occult Blood Tests
1.2.5 CRC DNA Screening Tests
1.3 Global In-Vitro Colorectal Cancer Screening Tests Market by Application
1.3.1 Overview: Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global In-Vitro Colorectal Cancer Screening Tests Market by Regions
1.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of In-Vitro Colorectal Cancer Screening Tests (2015-2025)
1.4.3 North America (USA, Canada and Mexico) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alere(Abbott)
2.1.1 Alere(Abbott) Details
2.1.2 Alere(Abbott) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alere(Abbott) SWOT Analysis
2.1.4 Alere(Abbott) Product and Services
2.1.5 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.2 QIAGEN
2.2.1 QIAGEN Details
2.2.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 QIAGEN SWOT Analysis
2.2.4 QIAGEN Product and Services
2.2.5 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eiken Chemical
2.3.1 Eiken Chemical Details
2.3.2 Eiken Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eiken Chemical SWOT Analysis
2.3.4 Eiken Chemical Product and Services
2.3.5 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter SWOT Analysis
2.4.4 Beckman Coulter Product and Services
2.4.5 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sysmex
2.5.1 Sysmex Details
2.5.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sysmex SWOT Analysis
2.5.4 Sysmex Product and Services
2.5.5 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthcare SWOT Analysis
2.6.4 Siemens Healthcare Product and Services
2.6.5 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.7 Immunostics
2.7.1 Immunostics Details
2.7.2 Immunostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Immunostics SWOT Analysis
2.7.4 Immunostics Product and Services
2.7.5 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.8 Clinical Genomics Pty Ltd (Quest Diagnostics)
2.8.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Details
2.8.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Clinical Genomics Pty Ltd (Quest Diagnostics) SWOT Analysis
2.8.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Product and Services
2.8.5 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hitachi Chemical (Kyowa Medex)
2.9.1 Hitachi Chemical (Kyowa Medex) Details
2.9.2 Hitachi Chemical (Kyowa Medex) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hitachi Chemical (Kyowa Medex) SWOT Analysis
2.9.4 Hitachi Chemical (Kyowa Medex) Product and Services
2.9.5 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
2.10 R-Biopharm
2.10.1 R-Biopharm Details
2.10.2 R-Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 R-Biopharm SWOT Analysis
2.10.4 R-Biopharm Product and Services
2.10.5 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 In-Vitro Colorectal Cancer Screening Tests Players Market Share
3.2.2 Top 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Market Share by Regions
4.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
4.3 Europe In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
4.5 South America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
5 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries
5.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
5.2 USA In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
5.3 Canada In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
5.4 Mexico In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
6 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Countries
6.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
6.2 Germany In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
6.3 UK In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
6.4 France In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
6.5 Russia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
6.6 Italy In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
7 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Countries
7.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
7.2 China In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
7.3 Japan In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
7.4 Korea In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
7.5 India In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
8 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries
8.1 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
8.2 Brazil In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
8.3 Argentina In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue In-Vitro Colorectal Cancer Screening Tests by Countries
9.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
9.2 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
9.3 UAE In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
9.4 Egypt In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
9.5 South Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Market Share by Type (2015-2020)
10.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Type (2019-2024)
10.3 Biomarker Tests Revenue Growth Rate (2015-2025)
10.4 Fecal Occult Blood Tests Revenue Growth Rate (2015-2025)
10.5 CRC DNA Screening Tests Revenue Growth Rate (2015-2025)
11 Global In-Vitro Colorectal Cancer Screening Tests Market Segment by Application
11.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2015-2020)
11.2 In-Vitro Colorectal Cancer Screening Tests Market Forecast by Application (2019-2024)
11.3 Hospital and Clinics Revenue Growth (2015-2020)
11.4 Ambulatory Revenue Growth (2015-2020)
11.5 Home Care Revenue Growth (2015-2020)
12 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecast (2021-2025)
12.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecast (2021-2025)
12.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Regions (2021-2025)
12.3 North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
12.4 Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
12.6 South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Alere(Abbott) Corporate Information, Location and Competitors
Table 6. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Major Business
Table 7. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 8. Alere(Abbott) SWOT Analysis
Table 9. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 10. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. QIAGEN Corporate Information, Location and Competitors
Table 12. QIAGEN In-Vitro Colorectal Cancer Screening Tests Major Business
Table 13. QIAGEN In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2018-2019)
Table 14. QIAGEN SWOT Analysis
Table 15. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 16. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eiken Chemical Corporate Information, Location and Competitors
Table 18. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Major Business
Table 19. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 20. Eiken Chemical SWOT Analysis
Table 21. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 22. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter Corporate Information, Location and Competitors
Table 24. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Major Business
Table 25. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter SWOT Analysis
Table 27. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 28. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sysmex Corporate Information, Location and Competitors
Table 30. Sysmex In-Vitro Colorectal Cancer Screening Tests Major Business
Table 31. Sysmex In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 32. Sysmex SWOT Analysis
Table 33. Sysmex In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 34. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Siemens Healthcare Corporate Information, Location and Competitors
Table 36. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Major Business
Table 37. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 38. Siemens Healthcare SWOT Analysis
Table 39. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 40. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Immunostics Corporate Information, Location and Competitors
Table 42. Immunostics In-Vitro Colorectal Cancer Screening Tests Major Business
Table 43. Immunostics In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 44. Immunostics SWOT Analysis
Table 45. Immunostics In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 46. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Information, Location and Competitors
Table 48. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Major Business
Table 49. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 50. Clinical Genomics Pty Ltd (Quest Diagnostics) SWOT Analysis
Table 51. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 52. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Hitachi Chemical (Kyowa Medex) Corporate Information, Location and Competitors
Table 54. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Major Business
Table 55. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 56. Hitachi Chemical (Kyowa Medex) SWOT Analysis
Table 57. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 58. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. R-Biopharm Corporate Information, Location and Competitors
Table 60. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Major Business
Table 61. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Total Revenue (USD Million) (2017-2018)
Table 62. R-Biopharm SWOT Analysis
Table 63. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 64. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Players (2015-2020)
Table 66. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players (2015-2020)
Table 67. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Regions (2015-2020)
Table 68. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Regions (2015-2020)
Table 69. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
Table 70. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Table 71. Europe In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Countries (2015-2020)
Table 73. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2015-2020)
Table 74. South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Table 77. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) by Type (2015-2020)
Table 78. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2015-2020)
Table 79. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Type (2021-2025)
Table 80. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2015-2020)
Table 81. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2015-2020)
Table 82. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Application (2021-2025)
Table 83. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. In-Vitro Colorectal Cancer Screening Tests Picture
Figure 2. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type in 2019
Figure 3. Biomarker Tests Picture
Figure 4. Fecal Occult Blood Tests Picture
Figure 5. CRC DNA Screening Tests Picture
Figure 6. In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application in 2019
Figure 7. Hospital and Clinics Picture
Figure 8. Ambulatory Picture
Figure 9. Home Care Picture
Figure 10. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players in 2019
Figure 18. Global Top 5 Players In-Vitro Colorectal Cancer Screening Tests Revenue Market Share in 2019
Figure 19. Global Top 10 Players In-Vitro Colorectal Cancer Screening Tests Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Regions (2015-2020)
Figure 23. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Regions in 2018
Figure 24. North America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 25. Europe In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 27. South America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 29. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Figure 30. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries in 2019
Figure 31. USA In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 32. Canada In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 33. Mexico In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 34. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Figure 35. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries in 2019
Figure 36. Germany In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 37. UK In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 38. France In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 39. Russia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 40. Italy In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries in 2019
Figure 43. China In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 44. Japan In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 45. Korea In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 46. India In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 48. South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Figure 49. South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries in 2019
Figure 50. Brazil In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 51. Argentina In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 55. UAE In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 56. Egypt In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 57. South Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2015-2020)
Figure 58. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2015-2020)
Figure 59. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type in 2019
Figure 60. Global In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Type (2021-2025)
Figure 61. Global Biomarker Tests Revenue Growth Rate (2015-2020)
Figure 62. Global Fecal Occult Blood Tests Revenue Growth Rate (2015-2020)
Figure 63. Global CRC DNA Screening Tests Revenue Growth Rate (2015-2020)
Figure 64. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2015-2020)
Figure 65. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application in 2019
Figure 66. Global In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital and Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Revenue Growth Rate (2015-2020)
Figure 69. Global Home Care Revenue Growth Rate (2015-2020)
Figure 70. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
Figure 74. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
Figure 76. South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
精密がん検査の世界市場 2020年 Market Overview The global Precision Cancer Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Precision Cancer Tests…- 腫瘍バイオマーカー検査の世界市場 2020年 Market Overview The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Biomarker Test mar…
- 乳がんスクリーニングの世界市場 2020年 Market Overview The Breast Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 体外診断システムの世界市場 2020年 Market Overview The global In Vitro Diagnostics Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In Vitro Diagnos…
- 大腸がん分子診断の世界市場 2020年 Market Overview The global Colorectal Cancer Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Color…